Clinical trial ENGOT-cx12 - SGNTV-003
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin versus Investigator's Choice Chemotherapy in Second or Third Line Recurrent or Metastatic Cervical Cancer
Cancers | |
---|---|
Organ | Uterus |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | Seagen |
EudraCT Identifier | 2019-001655-39 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04697628 |
Last update |